Urogen Pharma (NASDAQ:URGN) reported first-quarter 2026 results that management said showed accelerating early momentum from ...
Low-code automation software company Appian (NASDAQ:APPN) announced better-than-expected revenue in Q1 CY2026, with sales up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results